Q3 2024 Holdings
Filed 2024-11-14 | 93 holdings | $783.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $37.5M | 447,196 | 4.8% |
| Insulet Corp(PODD) | COM | 45784P101 | $37.2M | 159,689 | 4.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $35.8M | 40,384 | 4.6% |
| Cooper COS Inc(COO) | COM | 216648501 | $32.3M | 292,593 | 4.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $24.5M | 421,782 | 3.1% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $23.8M | 96,144 | 3.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $22.9M | 64,031 | 2.9% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $20.8M | 3,304,085 | 2.7% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $18.9M | 755,244 | 2.4% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $18.0M | 626,452 | 2.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $17.7M | 241,575 | 2.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $17.5M | 657,070 | 2.2% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $16.4M | 491,272 | 2.1% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $15.7M | 1,025,754 | 2.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $15.6M | 93,753 | 2.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $15.2M | 1,086,067 | 1.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $15.0M | 129,840 | 1.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $14.9M | 130,249 | 1.9% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $14.5M | 60,011 | 1.8% |
| Abbott Labs(ABT) | COM | 002824100 | $14.1M | 123,601 | 1.8% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $12.9M | 924,140 | 1.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $12.7M | 285,099 | 1.6% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $10.8M | 129,025 | 1.4% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $10.4M | 559,105 | 1.3% |
| Stryker Corporation(SYK) | COM | 863667101 | $10.1M | 28,000 | 1.3% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $10.1M | 445,396 | 1.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $9.9M | 438,971 | 1.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $9.8M | 508,283 | 1.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $9.7M | 425,000 | 1.2% |
| Qiagen NV(QGEN) | SHS NEW | N72482149 | $9.6M | 210,769 | 1.2% |
| Rxsight Inc(RXST) | COM | 78349D107 | $9.1M | 184,320 | 1.2% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $9.1M | 497,870 | 1.2% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $8.5M | 55,000 | 1.1% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $8.4M | 296,071 | 1.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $8.4M | 763,747 | 1.1% |
| Avid Bioservices Inc(PPHMEUR) | COM | 05368M106 | $8.2M | 719,965 | 1.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $8.1M | 72,256 | 1.0% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $7.7M | 907,294 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.5M | 191,658 | 1.0% |
| Icon PLC(ICLR) | SHS | G4705A100 | $7.5M | 26,212 | 1.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $7.2M | 195,000 | 0.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $7.0M | 25,485 | 0.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $6.5M | 605,318 | 0.8% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $6.1M | 109,468 | 0.8% |
| Cvrx Inc(CVRX) | COM | 126638105 | $6.0M | 682,897 | 0.8% |
| Sutro Biopharma Inc | COM | 869367102 | $5.9M | 1,716,132 | 0.8% |
| Axogen Inc(AXGN) | COM | 05463X106 | $5.8M | 412,888 | 0.7% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $5.6M | 66,492 | 0.7% |
| Performant Finl Corp(PFMTUSD) | COM | 71377E105 | $5.4M | 1,440,838 | 0.7% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $5.3M | 101,729 | 0.7% |